No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Antoinette Hollestelle; Frederieke H. van der Baan; Andrew Berchuck; Sharon E. Johnatty; Katja K. Aben; Bjarni A. Agnarsson; Kristiina Aittomäki; Elisa Alducci; Irene L. Andrulis; Hoda Anton-Culver; Natalia N. Antonenkova; Antonis C. Antoniou; Carmel Apicella; Volker Arndt; Norbert Arnold; Banu K. Arun; Brita Arver; Alan Ashworth; Laura Baglietto; Rosemary Balleine; Elisa V. Bandera; Daniel Barrowdale; Yukie T. Bean; Lars Beckmann; Matthias W. Beckmann; Javier Benitez; Andreas Berger; Raanan Berger; Benoit Beuselinck; Maria Bisogna; Line Bjorge; Carl Blomqvist; Natalia V. Bogdanova; Anders Bojesen; Stig E. Bojesen; Manjeet K. Bolla; Bernardo Bonanni; Judith S. Brand; Hiltrud Brauch; Hermann Brenner; Louise Brinton; Angela Brooks-Wilson; Fiona Bruinsma; Joan Brunet; Thomas Bruning; Ralf Butzow; Arto Leminen; Taru A. Muranen; Heli Nevanlinna; Liisa M. Pelttari; Ovarian Canc Assoc Consortium; Breast Canc Assoc Consortium; Consortium Modifiers BRCA1 & BRCA2; Australian Ovarian Canc Study Grp; Breast Cancer Family Register; EMBRACE; GEMO Study Collaborators; GENICA Network; HEBON; kConFab Investigators; SWE-BRCA

doi:10.1016/j.ygyno.2015.04.034

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Antoinette Hollestelle, Frederieke H. van der Baan, Andrew Berchuck, Sharon E. Johnatty, Katja K. Aben, Bjarni A. Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Antonis C. Antoniou, Carmel Apicella, Volker Arndt, Norbert Arnold, Banu K. Arun, Brita Arver, Alan Ashworth, Laura Baglietto, Rosemary BalleineElisa V. Bandera, Daniel Barrowdale, Yukie T. Bean, Lars Beckmann, Matthias W. Beckmann, Javier Benitez, Andreas Berger, Raanan Berger, Benoit Beuselinck, Maria Bisogna, Line Bjorge, Carl Blomqvist, Natalia V. Bogdanova, Anders Bojesen, Stig E. Bojesen, Manjeet K. Bolla, Bernardo Bonanni, Judith S. Brand, Hiltrud Brauch, Hermann Brenner, Louise Brinton, Angela Brooks-Wilson, Fiona Bruinsma, Joan Brunet, Thomas Bruning, Ralf Butzow, Arto Leminen, Taru A. Muranen, Heli Nevanlinna, Liisa M. Pelttari, Ovarian Canc Assoc Consortium, Breast Canc Assoc Consortium, Consortium Modifiers BRCA1 & BRCA2, Australian Ovarian Canc Study Grp , Breast Cancer Family Register, EMBRACE, GEMO Study Collaborators, GENICA Network , HEBON, kConFab Investigators, SWE-BRCA

Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review

Originalspråk	engelska
Tidskrift	Gynecologic Oncology
Volym	141
Nummer	2
Sidor (från-till)	386-401
Antal sidor	16
ISSN	0090-8258
DOI	https://doi.org/10.1016/j.ygyno.2015.04.034
Status	Publicerad - maj 2016
MoE-publikationstyp	A2 Granska artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

3123 Kvinno- och barnsjukdomar
3122 Cancersjukdomar

Åtkomst av dokument

10.1016/j.ygyno.2015.04.034

No clinical utility of KRAS variantSlutlig publicerad version, 673 KB

Citera det här

Hollestelle, A., van der Baan, F. H., Berchuck, A., Johnatty, S. E., Aben, K. K., Agnarsson, B. A., Aittomäki, K., Alducci, E., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Antoniou, A. C., Apicella, C., Arndt, V., Arnold, N., Arun, B. K., Arver, B., Ashworth, A., Baglietto, L., ... SWE-BRCA (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141(2), 386-401. https://doi.org/10.1016/j.ygyno.2015.04.034

@article{b14f94eab7224a1aa97a787e3540e7b2,

title = "No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer",

keywords = "KRAS variant, Breast cancer, Ovarian cancer, Genetic association, Clinical outcome, GENOME-WIDE ASSOCIATION, MICRORNA-BINDING-SITE, SUSCEPTIBILITY LOCI, RISK, PROSTATE, IDENTIFICATION, POLYMORPHISMS, ENDOMETRIOSIS, WOMEN, 3123 Gynaecology and paediatrics, 3122 Cancers",

author = "Antoinette Hollestelle and {van der Baan}, {Frederieke H.} and Andrew Berchuck and Johnatty, {Sharon E.} and Aben, {Katja K.} and Agnarsson, {Bjarni A.} and Kristiina Aittom{\"a}ki and Elisa Alducci and Andrulis, {Irene L.} and Hoda Anton-Culver and Antonenkova, {Natalia N.} and Antoniou, {Antonis C.} and Carmel Apicella and Volker Arndt and Norbert Arnold and Arun, {Banu K.} and Brita Arver and Alan Ashworth and Laura Baglietto and Rosemary Balleine and Bandera, {Elisa V.} and Daniel Barrowdale and Bean, {Yukie T.} and Lars Beckmann and Beckmann, {Matthias W.} and Javier Benitez and Andreas Berger and Raanan Berger and Benoit Beuselinck and Maria Bisogna and Line Bjorge and Carl Blomqvist and Bogdanova, {Natalia V.} and Anders Bojesen and Bojesen, {Stig E.} and Bolla, {Manjeet K.} and Bernardo Bonanni and Brand, {Judith S.} and Hiltrud Brauch and Hermann Brenner and Louise Brinton and Angela Brooks-Wilson and Fiona Bruinsma and Joan Brunet and Thomas Bruning and Ralf Butzow and Arto Leminen and Muranen, {Taru A.} and Heli Nevanlinna and Pelttari, {Liisa M.} and {Ovarian Canc Assoc Consortium} and {Breast Canc Assoc Consortium} and {Consortium Modifiers BRCA1 & BRCA2} and {Australian Ovarian Canc Study Grp} and {Breast Cancer Family Register} and EMBRACE and {GEMO Study Collaborators} and {GENICA Network} and HEBON and {kConFab Investigators} and SWE-BRCA",

year = "2016",

month = may,

doi = "10.1016/j.ygyno.2015.04.034",

language = "English",

volume = "141",

pages = "386--401",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "2",

}

Hollestelle, A, van der Baan, FH, Berchuck, A, Johnatty, SE, Aben, KK, Agnarsson, BA, Aittomäki, K, Alducci, E, Andrulis, IL, Anton-Culver, H, Antonenkova, NN, Antoniou, AC, Apicella, C, Arndt, V, Arnold, N, Arun, BK, Arver, B, Ashworth, A, Baglietto, L, Balleine, R, Bandera, EV, Barrowdale, D, Bean, YT, Beckmann, L, Beckmann, MW, Benitez, J, Berger, A, Berger, R, Beuselinck, B, Bisogna, M, Bjorge, L, Blomqvist, C, Bogdanova, NV, Bojesen, A, Bojesen, SE, Bolla, MK, Bonanni, B, Brand, JS, Brauch, H, Brenner, H, Brinton, L, Brooks-Wilson, A, Bruinsma, F, Brunet, J, Bruning, T, Butzow, R , Leminen, A , Muranen, TA , Nevanlinna, H , Pelttari, LM, Ovarian Canc Assoc Consortium, Breast Canc Assoc Consortium, Consortium Modifiers BRCA1 & BRCA2, Australian Ovarian Canc Study Grp , Breast Cancer Family Register, EMBRACE, GEMO Study Collaborators, GENICA Network , HEBON, kConFab Investigators & SWE-BRCA 2016, 'No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer', Gynecologic Oncology, vol. 141, nr. 2, s. 386-401. https://doi.org/10.1016/j.ygyno.2015.04.034

TY - JOUR

T1 - No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

AU - Hollestelle, Antoinette

AU - van der Baan, Frederieke H.

AU - Berchuck, Andrew

AU - Johnatty, Sharon E.

AU - Aben, Katja K.

AU - Agnarsson, Bjarni A.

AU - Aittomäki, Kristiina

AU - Alducci, Elisa

AU - Andrulis, Irene L.

AU - Anton-Culver, Hoda

AU - Antonenkova, Natalia N.

AU - Antoniou, Antonis C.

AU - Apicella, Carmel

AU - Arndt, Volker

AU - Arnold, Norbert

AU - Arun, Banu K.

AU - Arver, Brita

AU - Ashworth, Alan

AU - Baglietto, Laura

AU - Balleine, Rosemary

AU - Bandera, Elisa V.

AU - Barrowdale, Daniel

AU - Bean, Yukie T.

AU - Beckmann, Lars

AU - Beckmann, Matthias W.

AU - Benitez, Javier

AU - Berger, Andreas

AU - Berger, Raanan

AU - Beuselinck, Benoit

AU - Bisogna, Maria

AU - Bjorge, Line

AU - Blomqvist, Carl

AU - Bogdanova, Natalia V.

AU - Bojesen, Anders

AU - Bojesen, Stig E.

AU - Bolla, Manjeet K.

AU - Bonanni, Bernardo

AU - Brand, Judith S.

AU - Brauch, Hiltrud

AU - Brenner, Hermann

AU - Brinton, Louise

AU - Brooks-Wilson, Angela

AU - Bruinsma, Fiona

AU - Brunet, Joan

AU - Bruning, Thomas

AU - Butzow, Ralf

AU - Leminen, Arto

AU - Muranen, Taru A.

AU - Nevanlinna, Heli

AU - Pelttari, Liisa M.

AU - Ovarian Canc Assoc Consortium

AU - Breast Canc Assoc Consortium

AU - Consortium Modifiers BRCA1 & BRCA2

AU - Australian Ovarian Canc Study Grp

AU - Breast Cancer Family Register

AU - EMBRACE

AU - GEMO Study Collaborators

AU - GENICA Network

AU - HEBON

AU - kConFab Investigators

AU - SWE-BRCA

PY - 2016/5

Y1 - 2016/5

KW - KRAS variant

KW - Breast cancer

KW - Ovarian cancer

KW - Genetic association

KW - Clinical outcome

KW - GENOME-WIDE ASSOCIATION

KW - MICRORNA-BINDING-SITE

KW - SUSCEPTIBILITY LOCI

KW - RISK

KW - PROSTATE

KW - IDENTIFICATION

KW - POLYMORPHISMS

KW - ENDOMETRIOSIS

KW - WOMEN

KW - 3123 Gynaecology and paediatrics

KW - 3122 Cancers

U2 - 10.1016/j.ygyno.2015.04.034

DO - 10.1016/j.ygyno.2015.04.034

M3 - Review Article

SN - 0090-8258

VL - 141

SP - 386

EP - 401

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 2

ER -